Log in to save to my catalogue

High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the u...

High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the u...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8712308

High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics

About this item

Full title

High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

European journal of nuclear medicine and molecular imaging, 2021-12, Vol.49 (1), p.385-389

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
To evaluate fibroblast-activation-protein (FAP) expression in different clinical stages of prostate cancer (PC) with regards to utility of [
68
 Ga]Ga-FAPI-04 PET/CT imaging in patients with castration-resistant PC (CRPC).
Methods
Tissue microarrays (TMAs) were constructed from prostatic tissue from 94 patients at different s...

Alternative Titles

Full title

High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8712308

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8712308

Other Identifiers

ISSN

1619-7070,1619-7089

E-ISSN

1619-7089

DOI

10.1007/s00259-021-05423-y

How to access this item